Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

  • This is a preview / test site. Please update your PubMed URL to pubmed.gov.
1.

Pain management: Opioids for RA: a clinical dilemma.

Häuser W, Fitzcharles MA.

Nat Rev Rheumatol. 2017 Aug 3. doi: 10.1038/nrrheum.2017.123. [Epub ahead of print] No abstract available.

PMID:
28769111
2.

Another Nasty Effect of Opioids: Attenuating the Benefits of Motivational Interviewing in Fibromyalgia?

Fitzcharles MA, Shir Y.

J Rheumatol. 2017 Apr;44(4):407-409. doi: 10.3899/jrheum.170076. No abstract available.

PMID:
28604346
3.

The impact of moving from a widespread to multi-site pain definition on other fibromyalgia symptoms.

Dean LE, Arnold L, Crofford L, Bennett R, Goldenberg D, Fitzcharles MA, Paiva ES, Staud R, Clauw D, Sarzi-Puttini P, Jones GT, Ayorinde A, Fluß E, Beasley M, Macfarlane GJ.

Arthritis Care Res (Hoboken). 2017 Feb 9. doi: 10.1002/acr.23214. [Epub ahead of print]

PMID:
28182834
4.

Management of fibromyalgia: practical guides from recent evidence-based guidelines.

Häuser W, Ablin J, Perrot S, Fitzcharles MA.

Pol Arch Intern Med. 2017 Jan 4;127(1):47-56. doi: 10.20452/pamw.3877. Epub 2017 Jan 4. Review.

5.

Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.

Pomares FB, Funck T, Feier NA, Roy S, Daigle-Martel A, Ceko M, Narayanan S, Araujo D, Thiel A, Stikov N, Fitzcharles MA, Schweinhardt P.

J Neurosci. 2017 Feb 1;37(5):1090-1101. doi: 10.1523/JNEUROSCI.2619-16.2016. Epub 2016 Dec 16.

6.

2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Russell IJ, Walitt B.

Semin Arthritis Rheum. 2016 Dec;46(3):319-329. doi: 10.1016/j.semarthrit.2016.08.012. Epub 2016 Aug 30.

PMID:
27916278
7.

Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis.

Ste-Marie PA, Shir Y, Rampakakis E, Sampalis JS, Karellis A, Cohen M, Starr M, Ware MA, Fitzcharles MA.

Pain. 2016 Dec;157(12):2792-2797.

PMID:
27842047
8.

Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases.

Fitzcharles MA, Häuser W.

Curr Rheumatol Rep. 2016 Dec;18(12):76. doi: 10.1007/s11926-016-0625-5. Review.

PMID:
27832442
9.

Dr. Fitzcharles, et al, reply.

Fitzcharles MA, Ste-Marie PA, Rampakakis E, Sampalis JS, Shir Y.

J Rheumatol. 2016 Nov;43(11):2077. No abstract available.

PMID:
27803347
10.

Cannabinoids for fibromyalgia.

Walitt B, Klose P, Fitzcharles MA, Phillips T, Häuser W.

Cochrane Database Syst Rev. 2016 Jul 18;7:CD011694. doi: 10.1002/14651858.CD011694.pub2. Review.

PMID:
27428009
11.

Treat-to-Target Strategy for Fibromyalgia: Opening the Dialogue.

Häuser W, Clauw DJ, Fitzcharles MA.

Arthritis Care Res (Hoboken). 2017 Apr;69(4):462-466. doi: 10.1002/acr.22970. Epub 2017 Feb 28. Review. No abstract available.

PMID:
27390268
12.

Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders.

Ablin JN, Elkayam O, Fitzcharles MA.

Rambam Maimonides Med J. 2016 Apr 19;7(2). doi: 10.5041/RMMJ.10239.

13.

Pain Management for the Young Adult Rheumatology Patient in an Era of Medicinal Marijuana Legalization.

Fitzcharles MA, Hazel EM, Taylor G, Tucker LB.

J Rheumatol. 2016 Apr;43(4):686-8. doi: 10.3899/jrheum.150103. No abstract available.

PMID:
27037241
14.

Disability in Fibromyalgia Associates with Symptom Severity and Occupation Characteristics.

Fitzcharles MA, Ste-Marie PA, Rampakakis E, Sampalis JS, Shir Y.

J Rheumatol. 2016 May;43(5):931-6. doi: 10.3899/jrheum.151041. Epub 2016 Mar 15.

PMID:
26980580
16.

Medical use of cannabis products: Lessons to be learned from Israel and Canada.

Ablin J, Ste-Marie PA, Schäfer M, Häuser W, Fitzcharles MA.

Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.

PMID:
26767992
17.

Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials.

Fitzcharles MA, Ste-Marie PA, Häuser W, Clauw DJ, Jamal S, Karsh J, Landry T, Leclercq S, Mcdougall JJ, Shir Y, Shojania K, Walsh Z.

Arthritis Care Res (Hoboken). 2016 May;68(5):681-8. doi: 10.1002/acr.22727. Review.

18.

Real-life assessment of the validity of patient global impression of change in fibromyalgia.

Rampakakis E, Ste-Marie PA, Sampalis JS, Karellis A, Shir Y, Fitzcharles MA.

RMD Open. 2015 Sep 14;1(1):e000146. doi: 10.1136/rmdopen-2015-000146. eCollection 2015. Erratum in: RMD Open. 2015;1(1):e000146corr1.

19.

Comparison of Physician-Based and Patient-Based Criteria for the Diagnosis of Fibromyalgia.

Wolfe F, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, Mease PJ, Russell AS, Jon Russell I, Walitt B.

Arthritis Care Res (Hoboken). 2016 May;68(5):652-9. doi: 10.1002/acr.22742.

20.

Is a Responsive Default Mode Network Required for Successful Working Memory Task Performance?

Čeko M, Gracely JL, Fitzcharles MA, Seminowicz DA, Schweinhardt P, Bushnell MC.

J Neurosci. 2015 Aug 19;35(33):11595-605. doi: 10.1523/JNEUROSCI.0264-15.2015.

Items per page

Supplemental Content

Loading ...
Support Center